Heidi Paquette
Nurse Practitioner · Savannah, GANPI 1477196053
Payments from drug & device makers
Across 182 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$536
- AstraZeneca$525
- Amgen$417
- OPKO Pharmaceuticals, LLC$413
- Bayer$412
- Otsuka America Pharmaceutical, Inc.$260
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,52989%
- Education$43311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 29 | $536 |
| AstraZeneca | 23 | $525 |
| Amgen(2 entities) | 21 | $417 |
| OPKO Pharmaceuticals, LLC | 20 | $413 |
| Bayer | 20 | $412 |
| Otsuka America Pharmaceutical, Inc. | 12 | $260 |
| Novartis | 11 | $244 |
| Aurinia Pharma U.S., Inc. | 6 | $212 |
| Vifor Pharma, Inc. | 9 | $207 |
| Ardelyx, Inc. | 4 | $183 |
| Mallinckrodt Hospital Products Inc. | 6 | $142 |
| ANI Pharmaceuticals, Inc. | 5 | $92 |
| Calliditas Therapeutics US Inc. | 4 | $82 |
| Novo Nordisk | 3 | $62 |
| Lilly USA, LLC | 2 | $35 |
| Fresenius USA Marketing, Inc. | 2 | $33 |
| Organon | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $25 |
| GSK | 1 | $24 |
| Averitas Pharma Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,962 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 119 | $86,683 |
| RayaldeeCalcifediol | 62 | $76,958 |
| JardianceEmpagliflozin | 52 | $40,516 |
| KerendiaFinerenone | 43 | $30,734 |
| VeltassaPatiromer Calcium Sorbitex | 15 | $15,124 |
| OzempicSemaglutide | 11 | $11,783 |
| Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid | 44 | $6,552 |
| Telmisartan-AmlodipineTelmisartan/Amlodipine | 38 | $5,488 |
| Olmesartan Medoxomil | 126 | $1,599 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 56 | $1,153 |
| Allopurinol | 104 | $1,019 |
| Spironolactone | 93 | $974 |
| Valsartan | 43 | $724 |
| Telmisartan | 51 | $675 |
| Carvedilol | 87 | $554 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $525 | $86,683119 claims |
| OPKO Pharmaceuticals, LLCRayaldee | $413 | $76,95862 claims |
| BayerKerendia | $412 | $30,73443 claims |
| Novo NordiskOzempic | $62 | $11,78311 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $92 | $72443 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Savannah
- Crystal LogsdonSavannah$566K
- Jessica AdkinsSavannah$226K
- Luis PoloSavannah$70K
- Wallette WidenerSavannah$20K
- Angie MoyeSavannah$14K
- Amy CarterSavannah$11K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.